N※N

EDEN PRAIRIE, Minn.--([ BUSINESS WIRE ])--SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification technologies to the healthcare industry, announced today that it will participate in CL King's 10th Annual Best Ideas Conference in New York City on Wednesday, September 12, 2012. Gary Maharaj, SurModicsa President and Chief Executive Officer, and Timothy Arens, Vice President of Finance and interim Chief Financial Officer, will discuss the Companyas strategy and business conditions during a formal presentation beginning at 10:00 am EDT.

The presentation will be available via webcast by visiting the investor relations portion of the Company's website at [ www.surmodics.com ] on the day of the Conference and clicking the webcast icon. In addition, the Conference audio and slide presentation will be archived on the Company's website following the meeting.

About SurModics, Inc.

SurModicsa mission is to exceed our customersa expectations and enhance the well-being of patients by providing the worldas foremost, innovative surface modification technologies and in vitro diagnostic chemical components. The Company partners with the worldas leading and emerging medical device, diagnostic and life science companies to develop and commercialize innovative products designed to improve patient diagnosis and treatment. Core offerings include surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and microarrays. SurModics is headquartered in Eden Prairie, Minnesota.